このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

RPG Life Sciences 将来の成長

Future 基準チェック /06

現在、 RPG Life Sciencesの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Pharmaceuticals 収益成長	17.1%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

Aug 24

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jun 14

Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

Feb 09

Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

Jan 13

RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Dec 23

Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

Nov 11

Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Oct 21

Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

Sep 28

What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

Aug 31

With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

Aug 11

What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

Jul 28

Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jul 10

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、RPG Life Sciences は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

NSEI:RPGLIFE - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2024	5,821	877	251	944	N/A
12/31/2023	5,736	848	N/A	N/A	N/A
9/30/2023	5,505	774	354	896	N/A
6/30/2023	5,317	715	N/A	N/A	N/A
3/31/2023	5,128	676	581	908	N/A
12/31/2022	4,981	648	N/A	N/A	N/A
9/30/2022	4,831	603	343	612	N/A
6/30/2022	4,610	561	N/A	N/A	N/A
3/31/2022	4,402	515	408	648	N/A
12/31/2021	4,291	509	N/A	N/A	N/A
9/30/2021	4,211	491	696	808	N/A
6/30/2021	4,056	445	N/A	N/A	N/A
3/31/2021	3,891	400	498	583	N/A
12/31/2020	3,851	361	N/A	N/A	N/A
9/30/2020	3,718	311	239	316	N/A
6/30/2020	3,732	297	N/A	N/A	N/A
3/31/2020	3,756	290	394	502	N/A
12/31/2019	3,557	276	N/A	N/A	N/A
9/30/2019	3,523	249	458	675	N/A
6/30/2019	3,443	173	N/A	N/A	N/A
3/31/2019	3,302	108	261	458	N/A
12/31/2018	3,448	105	N/A	N/A	N/A
9/30/2018	3,495	107	N/A	N/A	N/A
6/30/2018	3,485	149	N/A	N/A	N/A
3/31/2018	3,440	135	-8	147	N/A
12/31/2017	3,360	141	N/A	N/A	N/A
9/30/2017	3,062	97	N/A	N/A	N/A
6/30/2017	2,948	62	N/A	N/A	N/A
3/31/2017	2,936	121	N/A	73	N/A
12/31/2016	3,029	229	N/A	N/A	N/A
9/30/2016	3,095	270	N/A	N/A	N/A
6/30/2016	2,993	194	N/A	N/A	N/A
3/31/2016	2,552	84	N/A	328	N/A
12/31/2015	2,758	141	N/A	N/A	N/A
9/30/2015	2,609	119	N/A	N/A	N/A
6/30/2015	2,501	20	N/A	N/A	N/A
3/31/2015	2,423	10	N/A	-20	N/A
12/31/2014	2,290	-42	N/A	N/A	N/A
9/30/2014	2,273	-98	N/A	N/A	N/A
6/30/2014	2,312	-1	N/A	N/A	N/A
3/31/2014	2,356	534	N/A	-56	N/A
12/31/2013	2,400	613	N/A	N/A	N/A
9/30/2013	2,333	582	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: RPGLIFEの予測収益成長が貯蓄率 ( 6.7% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: RPGLIFEの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: RPGLIFEの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: RPGLIFEの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: RPGLIFEの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: RPGLIFEの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

RPG Life Sciences 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Full year 2024 earnings released: EPS: ₹53.00 (vs ₹40.90 in FY 2023)

Upcoming dividend of ₹16.00 per share

RPG Life Sciences Limited, Annual General Meeting, Jul 16, 2024

RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

RPG Life Sciences Limited Recommends Equity Dividend for the Year Ended March 31, 2024

Full year 2024 earnings released: EPS: ₹53.01 (vs ₹40.90 in FY 2023)

RPG Life Sciences Limited to Report Q4, 2024 Results on Apr 30, 2024

Third quarter 2024 earnings released: EPS: ₹16.00 (vs ₹11.56 in 3Q 2023)

RPG Life Sciences Limited to Report Nine Months, 2024 Results on Feb 01, 2024

Second quarter 2024 earnings released: EPS: ₹15.64 (vs ₹12.08 in 2Q 2023)

Investor sentiment improves as stock rises 16%

RPG Life Sciences Limited to Report Q2, 2024 Results on Oct 18, 2023

RPG Life Sciences Limited Approves Dividend for the Financial Year Ended March 31, 2023

RPG Life Sciences Limited to Report Q1, 2024 Results on Jul 28, 2023

Full year 2023 earnings released: EPS: ₹40.90 (vs ₹31.13 in FY 2022)

Upcoming dividend of ₹12.00 per share at 1.2% yield

RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00

RPG Life Sciences Limited Recommends Payment of Final Dividend for the Financial Year 2022-23

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: ₹40.90 (vs ₹31.13 in FY 2022)

Third quarter 2023 earnings released: EPS: ₹11.56 (vs ₹8.85 in 3Q 2022)

RPG Life Sciences Limited to Report Q3, 2023 Results on Feb 01, 2023

Insufficient new directors

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹12.08 (vs ₹9.52 in 2Q 2022)

RPG Life Sciences Limited to Report Q2, 2023 Results on Oct 17, 2022

Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

RPG Life Sciences Limited Approves Dividend for the Financial Year Ended March 31, 2022

RPG Life Sciences Limited to Report Q1, 2023 Results on Aug 02, 2022

Full year 2022 earnings released: EPS: ₹31.13 (vs ₹24.19 in FY 2021)

Upcoming dividend of ₹9.60 per share

RPG Life Sciences Limited Proposes Final Dividend for the Financial Year Ended March 31, 2022

Now 20% undervalued

Now 21% undervalued

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: ₹31.13 (vs ₹24.19 in FY 2021)

RPG Life Sciences Limited to Report Q4, 2022 Results on Apr 29, 2022

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹9.52 (vs ₹6.74 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

First quarter 2022 earnings released: EPS ₹8.21 (vs ₹5.48 in 1Q 2021)

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Full year 2021 earnings released: EPS ₹24.19 (vs ₹17.54 in FY 2020)

RPG Life Sciences Limited Recommends Equity Dividend for the Financial Year Ended March 31, 2021

Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

New 90-day high: ₹406

RPG Life Sciences Limited to Report Q3, 2021 Results on Jan 25, 2021

Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

First half earnings released

Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

New 90-day high: ₹405

What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

RPG Life Sciences Limited to Report Q1, 2021 Results on Jul 31, 2020

Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘